World Health Organization. Guidelines for the clinical management of HIV infections in adults [J]. Geneva: WHO/GPA,1991: 2.
[4]
Esteves F, Gaspar J, Marques T. Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data[J]. Clin Microbiol Infect, 2010, 16(7): 878-884.
[5]
Lu JJ, Lee CH. Pneumocystis pneumonia[J]. J Formos Med Assoc, 2008, 107(11): 830-842.
[6]
Fujisawa T, Suda T, Matsuda H. Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection[J]. Respirology, 2009, 14(2): 203-209.
[7]
Nakamura H, Tateyama M, Tasato D, et al. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia[J]. Intern Med, 2009, 48(4): 195-202.
[8]
Watanabe T, Yasuoka A, Tanuma J, et al. Serum beta-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS[J]. Clin Infect Dis, 2009, 49(7): 1128-1131.
张彤, 吴昊, 张可, 等. 艾滋病患者死亡原因分析[J]. J Cap Univer Med Sci, 2002, 23(2): 148-150.
[11]
Saraceni V, King BS, Cavalcante SC, et al. Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil[J]. Int J Tuberc Lung Dis, 2008, 12(7): 769-772.
[12]
Alvarez-Martínez MJ, Moreno A, Miro JM, et al. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality[J]. Diagn Microbiol Infect Dis, 2008, 62(1): 34-43.
Department ot Health and Human Services, Panel on Clinical Practices for Treatment of HIV Infection, Kaiser HJ Family Foundation, et al. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. January 28, 200 by the Panel on Clinical Practices for Treatment for HIV Infection[J]. Dep Heal Human Ser, 2008: 1-139.
[15]
Mofenson LM, Brady MT, Danner S, et al. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics[J]. MMWR Recomm Rep, 2009, 58(11): 1-166.